314130 Stock Chart & Stats
₩2990.00
-₩110.00(-3.55%)
―
--
Day’s Range― - ―
52-Week Range₩2,440.00 - ₩10,180.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)428.53K
Market Cap
₩140.29B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.25
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding45,255,154
10 Day Avg. Volume297,013
30 Day Avg. Volume428,527
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
314130 FAQ
What was Genome & Co.’s price range in the past 12 months?
Genome & Co. lowest stock price was ₩2440.00 and its highest was ₩10180.00 in the past 12 months.
What is Genome & Co.’s market cap?
Genome & Co.’s market cap is ₩140.29B.
When is Genome & Co.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genome & Co.’s earnings last quarter?
Genome & Co. released its earnings results on May 15, 2026. The company reported -₩182.166 earnings per share for the quarter, missing the consensus estimate of N/A by -₩182.166.
Is Genome & Co. overvalued?
According to Wall Street analysts Genome & Co.’s price is currently Undervalued.
Does Genome & Co. pay dividends?
Genome & Co. does not currently pay dividends.
What is Genome & Co.’s EPS estimate?
Genome & Co.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genome & Co. have?
Genome & Co. has 45,255,154 shares outstanding.
What happened to Genome & Co.’s price movement after its last earnings report?
Genome & Co. reported an EPS of -₩182.166 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.789%.
Which hedge fund is a major shareholder of Genome & Co.?
Currently, no hedge funds are holding shares in KR:314130
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bioneer Corporation
―
Bio Solution Co., Ltd.
―
DuChemBIO Co., Ltd.
―
NKGen Biotech Korea Co., Ltd.
―
3billion, Inc.
―